Hamlet Pharma is a pharmaceutical company. Most research and development is carried out in the field of protein-lipid complexes, which are used in the treatment of various forms of cancer. The company has developed a tumoricidal protein-lipid complex that mainly is used in the treatment of breast cancer, bladder cancer, as well as in cases of cancer that are hard to treat. The company is based in Lund.
CEO
Chairman Of The Board
Board
| Name | Capital % | Votes % | Date |
|---|---|---|---|
| Catharina Svanborg | 53,36 | 53,36 | 2019-06-30 |
| Avanza Pension | 4,54 | 4,54 | 2019-06-30 |
| Nordnet Pensionsförsäkring | 4,13 | 4,13 | 2019-06-30 |
| FV Group AB | 1,90 | 1,90 | 2019-06-30 |
| Hans Nygren | 1,74 | 1,74 | 2019-06-30 |
| Fredrik Herslow | 1,58 | 1,58 | 2019-06-30 |
| Livförsäkringsbolaget Skandia | 0,81 | 0,81 | 2019-06-30 |
| Creative Invest One AB | 0,45 | 0,45 | 2019-06-30 |
| Olle Jönsson | 0,43 | 0,43 | 2019-06-30 |
| Arne Hjortsberg | 0,32 | 0,32 | 2019-06-30 |
2019-08-30 Bokslutskommuniké 2019
2019-11-21 Årsstämma 2019